Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 7, 2014, Pages 702-713

  Venkova, Kalina ^a   Christov, Alexander ^a   Kamaluddin, Zarine ^a   Kobalka, Peter ^b   Siddiqui, Saaid ^a   Hensley, Kenneth ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyotrophic lateral sclerosis; CRMP2; Neuromuscular junction; Neuropilin 1; NSC 34 motor neuronYlike cells; Semaphorin 3A

Indexed keywords

NEUROPILIN 1; NEUROPILIN 1 ANTIBODY; NEUROPROTECTIVE AGENT; PROTEIN ANTIBODY; SEMAPHORIN 3A; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISTAL AXONOPATHY; FEMALE; GROWTH CONE; LIFESPAN; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; MUSCLE DENERVATION; NEUROMUSCULAR SYNAPSE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; SIGNAL TRANSDUCTION; VENTRAL ROOT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES, BLOCKING; AXONS; CELLS, CULTURED; DATA INTERPRETATION, STATISTICAL; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; NEUROPILIN-1; POSTURAL BALANCE; SEMAPHORIN-3A; SIGNAL TRANSDUCTION; SPINAL NERVE ROOTS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

EID: 84903269446     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000086     Document Type: Article

References (29)

1. Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol 2004;185:232-40
2. Hensley K, Mhatre M, Mou S, et al. On the relation of oxidative stress to neuroinflammation: Lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 2006;8:2075-87
3. Bento-Abreu A, Van Damme P, Van Den Bosch L, et al. The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci 2010;31:2247-65
4. Bilsland LG, Sahai E, Kelly G, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA 2010;107:20523-28
5. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113-17
6. De Winter F, Vo T, Stam FJ, et al. The expression of the chemorepellent semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 2006;32:102-15
7. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: Making tracks toward neural connectivity. Curr Opin Neurobiol 2003;13:79-89
8. DeoRC, Schmidt EF, ElhabaziA, et al. Structural bases for CRMP function in plexin-dependent semaphorin 3A signaling. EMBO J 2004;23:9-22
9. Uchida Y, Ohshima T, Sasaki Y, et al. Semaphorin3A signaling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: Implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005;10:165-79
10. Lin PC, Chan PM, Hall C, et al. Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a Taxol-sensitive binding interaction. J Biol Chem 2011;286:41466-78
11. Niisato E, Nagai J, Yamashita N, et al. CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus. Dev Neurobiol 2012; 72: 1447-57
12. Duplan L, Bernard N, Casseron W, et al. Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death. J Neurosci 2010;30:785-96
13. Hensley K, Venkova K, Christov A. Emerging biological importance of central nervous system lanthionines. Molecules 2010;15:5581-94
14. Liang W-C, Dennis MS, Stawicki Y, et al. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol 2007;366:815-29
15. Pan Q, Chanthery Y, Liang W-C, et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 2007;11:53-67
16. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu Zn superoxide dismutase mutation. Science 1994;264:1772-75
17. Mead RJ, Bennett EJ, Kennerley AJ, et al. Optimised and rapid pre-clinical screening in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS One 2011;6:e23244
18. Saban MR, Sferra TJ, Davis CA, et al. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesicular BCG treatment. Am J Ren Physiol 2010;299:F1245-56
19. Grandclement C, Borg C. Neuropilins: A new target for cancer therapy. Cancers 2011;3:1899-928
20. Cashman NR, Durham HD, Blusztajn JK, et al. Neuroblastoma-spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 1992;194:209-21
21. Schmidt ERE, Pasterkamp RJ, van den Berg L. Axon guidance proteins: Novel therapeutic targets for ALS? Prog Neurobiol 2009;88:286-301
22. Hernandez S, Texido L, Caldero J, et al. Increased intramuscular nerve branching and inhibition of programmed cell death of chick motoneurons by immunoglobulins from patients with motoneuron disease. J Neuroimmunol 2010;229:157-68
23. Jubb AM, Strickland LA, Liu SD, et al. Neuropilin-1 expression in cancer and development. J Pathol 2012;226:50-60
24. Bumbaca D, Xiang H, Boswell CA, et al. Maximizing tumor exposure to antiYneuropilin-1 antibody requires saturation of non-tumor antigenic sinks in mice. Br J Pharmacol 2012;166:368-77
25. Kalil K, Li L, Hutchins BI. Signaling mechanisms in cortical axon growth, guidance, and branching. Front Neuroanat 2011;5:1-15
26. Van Hoecke A, Schoonaert L, Lemmens R, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 2012;18:1418-22
27. Cole AR, Noble W, van Aalten L, et al. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J Neurochem 2007;103:1132-44
28. Takata K, Kitamura Y, Nakata Y, et al. Involvement of WAVE1 accumulation in AA/APP pathologyYdependent tangle modification in Alzheimer's disease. Am J Pathol 2009;175:17-24
29. Good PF, Alapat D, Hsu A, et al. A role for semaphoring 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J Neurochem 2004;91:716-36